Strategic deployment of CHO expression platforms to deliver Pfizer's Monoclonal Antibody Portfolio

Publisher: John Wiley & Sons Inc

E-ISSN: 1520-6033|33|6|1463-1467

ISSN: 8756-7938

Source: BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol.33, Iss.6, 2017-11, pp. : 1463-1467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract